-
-
-
-
-
-
-
Morgan Stanley Upgrades Arrowhead Pharma (ARWR) to Overweight
-
-
-
-
-
-
-
Arrowhead Pharmaceuticals Inc. (ARWR) Tops Q1 EPS by 10c
-
-
-
-
-
-
-
Bernstein on Arrowhead Pharma (ARWR): 'Obesity Data Meets Our Solid Win Scenario'
-
-
-
-
-
-
-
Arrowhead Pharma (ARWR) PT Raised at Bernstein Ahead of Obesity Data Update
-
-
-
-
-
-
-
Arrowhead Pharma (ARWR) PT Raised to $80 at RBC Capital
-
-
-
-
-
-
-
Arrowhead Pharma's (ARWR) Redemplo Approved in FCS - Cantor Fitzgerald
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Arrowhead Pharma (ARWR)
-
413,555 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

